Endo Open To Settlement In US Vasostrict Showdown

Eagle Strongly Suggested ‘At-Risk’ Launch Is Possible

 
• By Dean Rudge
  
Wooden_Gavel
“This paragraph IV litigation is obviously a very important area of focus for us,” Endo acknowledges • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products